Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. ‘Friendly’ bacteria may impact COVID severity

    ... IMGSCT (Immunogenomics, Microbial Genetics and Single Cell Technology) cores, is co-investigator. Key resources include  BioVU , ...

    sommers - 03/16/2021 - 8:18am

  2. Targeting diabetic kidney disease

    ... the epidermal growth factor receptor (EGFR) is activated in mouse models of type 1 diabetes, and that drugs which inhibit EGFR prevent the ... progression of DN but also improved weight gain and reduced insulin resistance in mice. Their work suggests that pathways activated by EGFR ...

    sommers - 02/21/2019 - 9:51am

  3. Team explores diabetes drug’s ability to treat RSV infection

    ... reduces the inflammatory response to RSV infection in a mouse model of the disease. The findings were reported in the  Journal ... approved to treat type 2 diabetes. These drugs enhance insulin secretion from the pancreas by activating the glucagon-like peptide 1 ...

    sommers - 07/13/2018 - 9:56am

  4. Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

    ... partnership with Deerfield and grateful to the Center for Technology Transfer and Commercialization team—particularly Alan Bentley and ... of the Vice Provost for Research  and the  Center for Technology Transfer and Commercialization  continue to assist faculty ...

    sommers - 11/17/2020 - 2:53pm

  5. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

    ... The licensing agreement, facilitated by the  Center for Technology Transfer and Commercialization  and the Office of the Vice Provost ... diseases, including psoriasis, rosacea, acne, herpes type 1 and 2, and shingles.   “The research led by Dr. Hawiger has ...

    sommers - 10/30/2020 - 12:45pm

  6. Medtronic announces the acquisition of AiBiomed, a Vanderbilt licensee that developed the world’s first technology to identify parathyroid glands

    ... Medtronic, a global leader in medical technology, announced on October 29, 2020, that it has recently acquired ... PTeye™ parathyroid detection system. The only probe-based technology of its kind, the PTeye system is designed to help confirm ...

    sommers - 12/08/2020 - 11:15am

  7. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... multinational pharmaceutical companies interested in the Mcl-1 inhibitors for cancer developed by Stephen Fesik from the Department of ...

    steelmk - 11/15/2016 - 2:29pm

  8. Tech Connect, Vol. 7, Issue 6: Dates announced for Vanderbilt Pre-Flight Program

    ... Technology Spotlight: I-Wire A Biotension Measurement ... the small molecule inhibitors to Mcl-1 to 17 companies,  developed by Steve Fesik from the Department ...

    steelmk - 11/10/2016 - 7:45am

  9. Tech Connect, Vol. 7, Issue 7: CTTC welcomes UASP Fellow Tonny Omwansa

    ... of Nairobi. Tonny discussed innovation, entrepreneurship and technology transfer best practices with CTTC Licensing Officers and New ... Technology Spotlight: New Drug for Blood Clot: FXII Inhibitors ...

    steelmk - 11/10/2016 - 7:45am

  10. Vanderbilt-developed exosuit selected for innovation and entrepreneurship showcase in Washington, D.C.

    ... Bayh-Dole Act allowed us to develop this wearable assistive technology at Vanderbilt, prove out the science and then license it so HeroWear ...

    sommers - 12/08/2020 - 10:17am